Page last updated: 2024-10-30

meprobamate and Cardiac Failure

meprobamate has been researched along with Cardiac Failure in 2 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DE MICHELI, E1
PARENTI, B1
Goulon, M1
Barois, A1
Gajdos, P1
Labrousse, J1
Schortgen, G1
Van Amerongen, G1
Robert, JF1

Other Studies

2 other studies available for meprobamate and Cardiac Failure

ArticleYear
[The combination of meprobamate and phenylethylmalonylurea in therapy].
    Gazzetta medica italiana, 1963, Volume: 122

    Topics: Arteriosclerosis; Heart Failure; Humans; Hypertension; Hyperthyroidism; Meprobamate; Myocardial Infa

1963
[Physiopathologic and therapeutic problems raised by acute toxic pulmonary edema].
    Le Poumon et le coeur, 1970, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Age Factors; Aged; Barbiturates; Carbon Monoxide Poisoning; Child; Child, Prescho

1970